Benchmark Reiterates Buy Rating for Canopy Growth (WEED)

Canopy Growth (TSE:WEED)‘s stock had its “buy” rating reaffirmed by research analysts at Benchmark in a report issued on Tuesday. They presently have a C$100.00 price objective on the stock. Benchmark’s price objective would suggest a potential upside of 47.84% from the company’s previous close.

Several other analysts have also issued reports on WEED. Cormark upped their price target on shares of Canopy Growth from C$25.00 to C$33.00 in a research report on Thursday, June 28th. Canaccord Genuity upped their price target on shares of Canopy Growth from C$27.50 to C$32.00 in a research report on Thursday, June 28th. Eight Capital upped their price target on shares of Canopy Growth from C$40.00 to C$50.00 in a research report on Friday, July 6th. Finally, Cowen upped their price target on shares of Canopy Growth from C$56.00 to C$74.00 in a research report on Tuesday, September 4th.

TSE WEED opened at C$67.64 on Tuesday. Canopy Growth has a 1 year low of C$10.61 and a 1 year high of C$74.45.

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

Featured Story: Using the New Google Finance Tool

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply